Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4284448 | 0.93 | NPC1 (0.34) | NPC1ALDH1A1LMNAHPGDTSHR | |
| SCHEMBL4769839 | 0.87 | NPC1 (0.33) | NPC1ALDH1A1LMNAHPGDTSHR | |
| SCHEMBL4425849 | 0.84 | NPC1 (0.37) | NPC1ALDH1A1LMNAHPGDTSHR | |
| SCHEMBL4529223 | 0.78 | HKDC1 (0.40) | NPC1ALDH1A1LMNAHPGDTSHR | |
| SCHEMBL4512742 | 0.77 | CNR1 (0.39) | NPC1ALDH1A1LMNAHPGDTSHR | |
| SCHEMBL4521064 | 0.75 | HKDC1 (0.40) | NPC1ALDH1A1LMNAHPGDTSHR | |
| SCHEMBL4510793 | 0.72 | HKDC1 (0.39) | NPC1ALDH1A1LMNAHPGDTSHR | |
| SCHEMBL4776782 | 0.70 | CDK1 (0.33) | NPC1LMNAHPGDTSHRRAB9A | |
| SCHEMBL4357095 | 0.69 | MAT2A (0.38) | NPC1ALDH1A1LMNAHPGDTSHR | |
| SCHEMBL4768907 | 0.69 | SMN1; SMN2 (0.34) | NPC1ALDH1A1LMNAHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1881988-A1 | 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) | MERCK SHARP & DOHME LTD. (GB) | 2008-01-30 | — | — | EP | disclosed |
| WO-2006122200-A1 | 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) | MERCK SHARP & DOHME LIMITED (GB) | 2006-11-16 | — | — | WO | disclosed |